About the Authors
- Ilya Gurevic
-
Contributed equally to this work with: Ilya Gurevic, Loic Meudec
Roles Formal analysis, Methodology, Writing – original draft, Writing – review & editing
Affiliation Department of Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, United States of America
- Loic Meudec
-
Contributed equally to this work with: Ilya Gurevic, Loic Meudec
Roles Conceptualization, Data curation, Formal analysis, Methodology, Visualization, Writing – original draft, Writing – review & editing
Affiliation Center for Immunology of Viral Infections and Autoimmune Diseases, INSERM UMR, Université Paris-Saclay, Le Kremlin-Bicêtre, Paris, France
- Xavier Mariette
-
Roles Conceptualization, Funding acquisition, Methodology, Supervision, Writing – review & editing
Affiliations Université Paris-Saclay, Center for Immunology of Viral Infections and Auto-immune Diseases (IMVA), Institut pour la Santé et la Recherche Médicale (INSERM) UMR, Le Kremlin-Bicêtre, Paris, France, Assistance Publique – Hôpitaux de Paris, Hôpital Bicêtre, Department of Rheumatology, Le Kremlin Bicêtre, France.
- Gaetane Nocturne
-
Roles Conceptualization, Methodology, Supervision, Writing – review & editing
Affiliations Université Paris-Saclay, Center for Immunology of Viral Infections and Auto-immune Diseases (IMVA), Institut pour la Santé et la Recherche Médicale (INSERM) UMR, Le Kremlin-Bicêtre, Paris, France, Assistance Publique – Hôpitaux de Paris, Hôpital Bicêtre, Department of Rheumatology, Le Kremlin Bicêtre, France.
- Sara S. McCoy
-
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing
* E-mail: ssmccoy@medicine.wisc.edu
Affiliation Department of Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, United States of America
Competing Interests
SSM is a consultant for Aurinia, Novartis, BMS, Amgen, Target RWE, Kiniksa, Otsuka/Visterra, and iCell. XM received consultant fees from BMS, GSK, Novartis, Otsuka and Pfizer. This study received support from Pfizer. This does not alter our adherence to PLOS ONE policies on sharing and materials. There are no patents, products in development or marketed products associated with this research to declare.